E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline

About this episode

Laura Beaton discusses the new 2025 Australian guideline on secondary prevention of acute coronary syndromes with David Brieger.

Laura Beaton chats with David Brieger, head of cardiology at Concord Hospital, Sydney, about the 2025 Australian acute coronary syndromes [ACS] clinical guideline. David explains the importance of secondary prevention for ACS, including new approaches to tailoring the duration of dual antiplatelet therapies, new lipid targets, and the limited role of beta blockers and colchicine. Read the full article in Australian Prescriber.

People in this episode

Host: Laura Beaton

Guest: David Brieger

Topics covered

• secondary prevention
• acute coronary syndromes
• clinical guidelines
• dual antiplatelet therapies
• lipid targets

Keywords

• acute coronary syndromes
• secondary prevention
• dual antiplatelet therapy
• lipid targets
• beta blockers

Mentioned in this episode

Organizations: Concord Hospital, Australian Prescriber

More episodes of Australian Prescriber Podcast

• E213 - Metabolic dysfunction–associated fatty liver disease an update · April 27, 2026 · 16 min
• E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals · April 13, 2026 · 24 min
• E211 - Preventing infections in immunosuppressed patients · March 30, 2026 · 24 min
• E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective? · March 16, 2026 · 19 min
• E208 - Pharmacological management of attention deficit hyperactivity disorder in adults · February 16, 2026 · 21 min
• E207 - Injectable drugs for weight management · February 2, 2026 · 23 min